Across Massachusetts, life sciences companies and healthcare organizations are collecting data: genome sequences, drug screens, clinical trial data, electronic medical records, claims data, and even patient-reported data. How we connect, analyze, organize and use that data presents an opportunity for our emerging life sciences informatics cluster that’s second to none. What is the market opportunity at the intersection of life sciences and technology and how can Massachusetts position itself as a world-leader in LSIX?

Join MassBio, MassTLC and leaders from life sciences, technology innovation, academics, venture capital, government and more to explore the challenges, implementations, and emerging opportunities in Life Sciences technology and informatics in the region.

More speakers to be announced – check back for additional details, or click here to sign up to receive email alerts for this event!

WHO SHOULD ATTEND:

WHAT YOU WILL LEARN:

1. How life sciences and technology companies are partnering in unique ways to solve business and scientific challenges
2. What the market opportunities are at the intersection of life sciences and technology, and how can Massachusetts position itself as a world-leader in LSIX
3. What investors look for in new LSIX ventures and how Massachusetts’ entrepreneurs can differentiate themselves in a competitive funding environment
4. How life sciences companies build their data science teams, internally and externally, and metrics for success